Villanueva, Jerum Jr. A.
HRN: 23-70-76 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/14/2023
CEFTRIAXONE 1G (VIAL)
09/14/2023
09/20/2023
IV
1.6g
OD
Immunocompromised State
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes